This article explores the challenges of oral glutathione (GSH) supplementation and how liposomal delivery technology significantly improves its stability, absorption, and overall bioavailability. It begins by explaining the biochemical vulnerability of GSH in the digestive tract, citing oxidation, enzymatic degradation, and poor uptake as primary obstacles. The piece then examines how liposomal encapsulation solves these problems by protecting GSH in the stomach and enhancing cellular absorption. Backed by scientific studies, the article offers compelling reasons for both consumers and B2B buyers to consider liposomal GSH as a superior delivery method in supplement development.